Which listed company is Mabaloshavi associated with in China?

Roche China listed company. As of July 7, 2022, Roche China listed company announced that it had been officially approved by the State Pharmaceutical Products Supervision and Administration, and its innovative influenza drug Sufuda (Chinese common name: Mabaroxavir) was listed, which was a cooperative relationship with the brand and was used to treat acute influenza patients aged 65,438+02 and above, with no complications and strong curative effect.